Exagamglogene autotemcel (exa-cel) gene therapy offers a potential cure for severe sickle cell disease, now available on NHS.

A group of sustainable finance experts tasked with advising the European Union have proposed changes to the bloc's rules for ...

In a shift away from GMOS, aka genetically modified organisms, important research is continuing in gene editing, sometimes ...

Deregulating New Zealand's gene tech space has been long-desired, but critics say the Government's growth-focused approach goes too far and risks too much, reports Fox Meyer ...

Gene technology has been earmarked for expansion in New Zealand, but without robust regulation local communities could be ...